436 related articles for article (PubMed ID: 14750496)
1. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
2. Congo red analogues as potential anti-prion agents.
Villa S; Cignarella G; Barlocco D; Gervasoni M; Carcassola G; Giannino L; Mantegazza P
Farmaco; 2003 Sep; 58(9):929-37. PubMed ID: 13679188
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters.
Poli G; Martino PA; Villa S; Carcassola G; Giannino ML; Dall'Ara P; Pollera C; Iussich S; Tranquillo VM; Bareggi S; Mantegazza P; Ponti W
Arzneimittelforschung; 2004; 54(7):406-15. PubMed ID: 15344846
[TBL] [Abstract][Full Text] [Related]
4. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.
Priola SA; Caughey B; Raymond GJ; Chesebro B
Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655
[TBL] [Abstract][Full Text] [Related]
5. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
6. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides.
Chabry J; Caughey B; Chesebro B
J Biol Chem; 1998 May; 273(21):13203-7. PubMed ID: 9582363
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of quinacrine treatment for prion diseases.
Barret A; Tagliavini F; Forloni G; Bate C; Salmona M; Colombo L; De Luigi A; Limido L; Suardi S; Rossi G; Auvré F; Adjou KT; Salès N; Williams A; Lasmézas C; Deslys JP
J Virol; 2003 Aug; 77(15):8462-9. PubMed ID: 12857915
[TBL] [Abstract][Full Text] [Related]
9. Effect of Congo red on wild-type and mutated prion proteins in cultured cells.
Milhavet O; Mangé A; Casanova D; Lehmann S
J Neurochem; 2000 Jan; 74(1):222-30. PubMed ID: 10617123
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.
Priola SA; Caughey B
Mol Neurobiol; 1994; 8(2-3):113-20. PubMed ID: 7999307
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster.
Corato M; Ogliari P; Ceciliani F; Cova E; Bellotti V; Cereda C; Merlini G; Ceroni M
Anticancer Res; 2009 Jul; 29(7):2507-12. PubMed ID: 19596920
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of scrapie-associated PrP accumulation by congo red.
Caughey B; Race RE
J Neurochem; 1992 Aug; 59(2):768-71. PubMed ID: 1352803
[TBL] [Abstract][Full Text] [Related]
13. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
[TBL] [Abstract][Full Text] [Related]
14. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of cellular prion protein is initiated by proximity-induced dimerization.
Goggin K; Bissonnette C; Grenier C; Volkov L; Roucou X
J Neurochem; 2007 Aug; 102(4):1195-205. PubMed ID: 17663754
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice.
Brown DA; Bruce ME; Fraser JR
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):262-72. PubMed ID: 12787323
[TBL] [Abstract][Full Text] [Related]
17. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
18. Two alternative pathways for generating transmissible prion disease de novo.
Makarava N; Savtchenko R; Baskakov IV
Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
[TBL] [Abstract][Full Text] [Related]
19. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
20. Abnormal properties of prion protein with insertional mutations in different cell types.
Priola SA; Chesebro B
J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
